Orit Lidor - Clal Biotechnology Insider

Clal Biotechnology Industries Ltd -- Israel Stock  

ILS 330.1  6  1.85%

VP and General Counsel

We currently do not have informatin regarding Orit Lidor. This executive tanure with Clal Biotechnology Industries Ltd is not currenlty determined.
Age: 35  VP Since 2011      
972 3 612 1616  http://www.cbi.co.il

Management Efficiency

The company has return on total asset (ROA) of (6.16) % which means that it has lost $6.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (0.2) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 85.49 M in total debt with debt to equity ratio (D/E) of 0.09 which may suggest the company is not taking enough advantage from borrowing. Clal Biotechnology Industries Ltd has Current Ratio of 3.23 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 3 records

VP Since

Yitzhak MosheOil Refineries Ltd
2014
Eyal KamilBezeq The Israel Telecommunicat
2006
Yaron NimrodOil Refineries Ltd
2013

Entity Summary

Clal Biotechnology Industries Ltd. is a private equity and VC firm specializing in development stage, preclinical; incubation, seed, startup, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. Clal Biotechnology Industries Ltd (CBI) is traded on Tel Aviv Stock Exchange in Israel. It is located in Tel Aviv, and employs 14 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Clal Biotechnology Industries Ltd to your portfolio

Top Management

Clal Biotechnology I Leadership Team
Ofer Goldberg, VP
Sigalia Heifetz, Director
Shmuel Rubinstein, Director
Aharon Yaari, Director
Dafna Gruber, Director
Aharon Schwartz, Director
Gavriel Barabash, Director, Ph.D
Isaac Kohlberg, Director, MBA
Jonathan Kaplan, Director
MA BSc, CEO
Assaf Segal, CFO, MBA
Ofer Gonen, President
Avraham Fischer, Chairman
Avraham Zigelman, Director
Yuval Yanai, Director
Julian Adams, President
Orit Lidor, VP
Ruben Krupik, CEO

Stock Performance

Clal Biotechnology Performance Indicators